SCHEMBL12875869

SCHEMBL12875869

CNC(=O)c1ccc(-c2ccc(OC)nc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 2/20 0.68
MKNK2 Q9HBH9 2/20 0.68
CD274 Q9NZQ7 1/20 0.55
PLK1 P53350 1/20 0.53
NNMT P40261 1/20 0.53
HDAC6 Q9UBN7 2/20 0.52
HDAC3 O15379 1/20 0.52
HSD17B1 P14061 1/20 0.50
HSD17B2 P37059 1/20 0.50
OXTR P30559 1/20 0.49
HDAC1 Q13547 1/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
TTK P33981 1/20 0.47
CLK2 P49760 1/20 0.47
PIK3CG P48736 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
KEAP1 Q14145 1/20 0.47
NFE2L2 Q16236 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14516103 0.87 NNMT (0.64) MKNK1MKNK2PLK1NNMTHDAC6
SCHEMBL27873385 0.86 MKNK1 (0.70) MKNK1MKNK2CD274NNMTHDAC6
SCHEMBL2225323 0.86 KCNH2 (0.63) MKNK1MKNK2
SCHEMBL13702343 0.84 MEN1 (0.63) MKNK1MKNK2HDAC6HDAC3HSD17B1
SCHEMBL2945799 0.84 MKNK1 (0.71) MKNK1MKNK2CD274NNMTHDAC6
SCHEMBL30280631 0.82 MKNK1 (0.73) MKNK1MKNK2CD274NNMTHDAC6
SCHEMBL29365356 0.82 MKNK1 (0.73) MKNK1MKNK2CD274NNMTHDAC6
SCHEMBL1870306 0.82 MKNK1 (0.73) MKNK1MKNK2CD274NNMTHDAC6
SCHEMBL12641872 0.82 MKNK1 (0.73) MKNK1MKNK2CD274NNMTHDAC6
SCHEMBL12582087 0.78 MKNK1 (0.68) MKNK1MKNK2CD274NNMTHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011017564-A2 IDENTIFICATION AND USE OF COMPOUNDS FOR TREATING PERSISTENT PAIN CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2011-02-10 WO disclosed